Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History VIR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics VIR

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Vir Biotechnology Inc

VIR
Current price
5.49 USD +0.06 USD (+1.10%)
Last closed 5.30 USD
ISIN US92764N1028
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 747 867 584 USD
Yield for 12 month -46.28 %
1Y
3Y
5Y
10Y
15Y
VIR
21.11.2021 - 28.11.2021

Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). It has grant agreements with Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California. Address: 1800 Owens Street, San Francisco, CA, United States, 94158

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

17.88 USD

P/E Ratio

Dividend Yield

Financials VIR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures VIR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+74 205 000 USD

Last Year

+86 180 000 USD

Current Quarter

+1 794 000 USD

Last Quarter

+12 374 000 USD

Current Year

+73 360 000 USD

Last Year

+83 415 000 USD

Current Quarter

+1 794 000 USD

Last Quarter

+10 594 000 USD
EBITDA -570 609 984 USD
Operating Margin TTM -4 568.83 %
Price to Earnings
Return On Assets TTM -23.52 %
PEG Ratio
Return On Equity TTM -44.59 %
Wall Street Target Price 17.88 USD
Revenue TTM 20 861 000 USD
Book Value 7.56 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -94.60 %
Dividend Yield
Gross Profit TTM -476 864 992 USD
Earnings per share -4.23 USD
Diluted Eps TTM -4.23 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY 58.50 %
Profit Margin

Stock Valuation VIR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 4.36
Enterprise Value Revenue 3.83
Price Sales TTM 35.85
Enterprise Value EBITDA 0.90
Price Book MRQ 0.73

Technical Indicators VIR

For 52 Weeks

4.32 USD 14.45 USD
50 Day MA 5.21 USD
Shares Short Prior Month 11 367 540
200 Day MA 7.29 USD
Short Ratio 7.84
Shares Short 11 221 883
Short Percent 13.29 %